University of California San Francisco

Publications

  1. ASO Visual Abstract: Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy-A Data-Driven, Machine Learning Approach to Augment Clinical Judgement.
    Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM
    Ann Surg Oncol. 2023 Sep; 30(9):5445-5446.; 
    PubMed
  2. Predicting Severe Complications from Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Data-Driven, Machine Learning Approach to Augment Clinical Judgment.
    Adam MA, Zhou H, Byrd J, Greenberg AL, Kelly YM, Hall L, Jones HL, Pingpank JF, Lipton ZC, Bartlett DL, Choudry HM
    Ann Surg Oncol. 2023 Sep; 30(9):5433-5442.; 
    PubMed
  3. Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States.
    Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Eng OS, Monson JRT, Ruff SM, Kasumova GG, Adam MO, Obeng-Gyasi S, Pawlik TM, Kim AC
    Front Oncol. 2022; 12:970237.; 
    PubMed
  4. Disparities in Care Access to Liver-Directed Therapy Among Medicare Beneficiaries with Colorectal Cancer Liver Metastasis.
    Aquina CT, Brown ZJ, Beane JD, Ejaz A, Cloyd JM, Tsung A, Adam MO, Pawlik TM, Kim AC
    Ann Surg Oncol. 2023 Jan; 30(1):335-344.; 
    PubMed
  5. Neoadjuvant Therapy Versus Upfront Resection for Nonpancreatic Periampullary Adenocarcinoma.
    Adam MA, Glencer A, AlMasri S, Winters S, Bahary N, Singhi A, Lee KK, Paniccia A, Zureikat AH
    Ann Surg Oncol. 2023 Jan; 30(1):165-174.; 
    PubMed
  6. ASO Author Reflections: Neoadjuvant Therapy for Nonpancreatic Periampullary Adenocarcinoma.
    Adam MA, Glencer AC, Zureikat AH
    Ann Surg Oncol. 2023 01; 30(1):175-176.; 
    PubMed
  7. ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
    Adam MA, Paniccia A
    Ann Surg Oncol. 2021 Jul; 28(7):3808-3809.; 
    PubMed
  8. Development of stability-indicating methods for cefquinome sulphate.
    Shantier SW, Gadkariem EA, Adam MO, Mohamed MA
    Int J Biomed Sci. 2013 Sep; 9(3):162-7.; 
    PubMed